No Picture
News

Ligand Provides a Corporate Update and Announces May 6th as the Date for First Quarter Earnings Call

SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) provides a general corporate update, as follows: ?As the business environment has evolved in response to the pandemic, Ligand has remained sharp with our operations and our … […]

No Picture
News

Shenogen enters into an Exclusive License with BioArdis to Develop and Commercialize Novel FGFR4 Kinase Inhibitor for Asian Market

BEIJING and?SHANGHAI and SAN DIEGO, April 3, 2020 /PRNewswire/ — Shenogen,?a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in China … […]

No Picture
News

Shenogen enters into an Exclusive License with BioArdis to Develop and Commercialize Novel FGFR4 Kinase Inhibitor for Asian Market

BEIJING and?SHANGHAI and SAN DIEGO, April 3, 2020 /PRNewswire/ — Shenogen,?a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in China … […]

No Picture
News

SORRENTO TO PROVIDE MANUFACTURING SUPPORT TO CELULARITY AS CYNK-001 NK CELL TRIAL FOR COVID-19 BEGINS ENROLLING PATIENTS

SAN DIEGO, April 02, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced it has initiated the next phase of its collaboration with Celularity, Inc., a Warren, New Jersey, based clinical-stage cell therapeutics co… […]

No Picture
News

Persephone Biosciences Announces AI-Driven Microbiome Therapeutic and Diagnostic Programs for COVID-19

Treatment approach goes beyond combating COVID-19 and may be effective against mutations, seasonal flu and future pandemics

SAN DIEGO, April 2, 2020 /PRNewswire/ — Persephone Biosciences Inc., a biotechnology company that designs microbiome therape… […]

No Picture
News

Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment

Treatment with DAS181, a clinical-stage recombinant biologic, reduced or eliminated the need for supplemental oxygen, and improved key patient vital signs

SAN DIEGO, April 2, 2020 /PRNewswire/ –?Ansun Biopharma, Inc., a clinical stage biopharmaceuti… […]

No Picture
News

Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy to Treat Parkinson Disease

SAN DIEGO, April 1, 2020 /PRNewswire/ — Aspen Neuroscience, a private biotechnology company developing the first autologous neuron replacement therapy to treat Parkinson disease, today announced the close of its Series A funding round of $70 millio… […]

No Picture
News

Trovagene Announces Acceptance of Phase 1b/2 KRAS-Mutated Metastatic Colorectal Cancer (mCRC) Trial Abstract for Presentation at the 2020 ASCO Annual Meeting

SAN DIEGO, April 1, 2020 /PRNewswire/ –?Trovagene, Inc. (Nasdaq:?TROV), a clinical-stage, oncology therapeutics company developing onvansertib for the treatment of various cancers including colorectal, prostate and leukemia, announced today that it… […]

No Picture
News

Cue Health Awarded $13 Million for Rapid, Portable, Point-of-Care COVID-19 Test by U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (?BARDA?)

SAN DIEGO, March 31, 2020 (GLOBE NEWSWIRE) — Cue Health Inc. (?Cue?), a healthcare technology company, announced that is has been awarded a $13 million contract to accelerate the development, validation and FDA clearance of a portable, molecular dia… […]

No Picture
News

SORRENTO AND THE UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON ENTER INTO PRECLINICAL TESTING AGREEMENT FOR COVID-19 THERAPEUTIC CANDIDATES

SAN DIEGO, March 31, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”), announced it has entered into a research testing agreement with The University of Texas Medical Branch at Galveston for the preclinical testing of S… […]